MCI-186

A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

PK Study in Subjects With Severe Hepatic Impairment

Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III